RemeGen Co Ltd REGMY:OTCPK

RT Quote | Exchange | USD
Last | EST
UNCH (UNCH)
52 week range
0.00 - 0.00

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close-
  • 52 Week High0.00
  • 52 Week High Date-
  • 52 Week Low0.00
  • 52 Week Low Date-
  • Market Cap6,956.88M
  • Shares Out478.36M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest RemeGen Co Ltd News

There is no recent news for this security.

Latest REGMY News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
RemeGen Co Ltd is a China-based company engaged in research, development and commercialization of biological drugs. The Company's clinical-stage drug candidates include telitacicept (RC18) used for the treatment of systemic lupus erythematosus, and disitamab vedotin (RC48) used for the treatment of gastric cancer.
Address
No.1 Rongchang Road, Yantai ETDZ
Yantai, SDG
264006
China